Sanford Bernstein

Dendreon to cut 500 jobs

Friday, September 9, 2011

Dendreon has reported it will cut 500 jobs as it seeks to trim expenses in light of diminished sales expectations for its high-priced Provenge prostate cancer vaccine, according to Reuters.

[Read More]